Therefore, we suggest that the inhibition of NSCLC cell growth by Anwulignan is correlated with G1 phase cell cycle arrest due to a reduction in cyclin D1 and cyclin D3 expression and an induction in p21 expression. Here, CCND1 is linked to non-small cell lung carcinoma.